Wenhe Zhu

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Topics

Signaling Pathway

Top Venues

Journal of materials chemistry. B

Biomaterials science

This page only lists publications with an associated author ORCID identifier.

Publications

Yawei Li, Wei Zhang, Naiyuan Shi, Wenqing Li, Junxia Bi, Xianmin Feng, Nianqiu Shi, Wenhe Zhu, Zhigang Xie
Self-assembly and self-delivery of the pure nanodrug dihydroartemisinin for tumor therapy and mechanism analysis. Biomaterials science (2023)
Yawei Li, Nianqiu Shi, Wei Zhang, Hong Zhang, Yu Song, Wenhe Zhu, Xianmin Feng
Supramolecular hybrids of carbon dots and dihydroartemisinin for enhanced anticancer activity and mechanism analysis. Journal of materials chemistry. B 8 (42) (2021)
Jing Zhang, Lei Liu, Lu Wang, Wenhe Zhu, Huiyan Wang
pH responsive zwitterionic-to-cationic transition for safe self-defensive antibacterial application. Journal of materials chemistry. B 8 (38) (2021)
Lu Tang, Lixia Zhang, Lei Liu, Liping Dong, Yuan Dong, Wenhe Zhu, Huiyan Wang
NCOR1 may be a potential biomarker of a novel molecular subtype of prostate cancer. FEBS open bio 10 (12) (2020)
Wenhe Zhu, Lei Liu, Yuan Dong, Guixian Meng, Lu Tang, Yan Li, Jianhui Cai, Huiyan Wang
Identification and characterization of a T-2 toxin-producing Fusarium poae strain and the anti-tumor effect of the T-2 toxin on human hepatoma cell line SMMC-7721. RSC advances 9 (16) (2019)
Wenhe Zhu, Wei Zhang, Na Xu, Yawei Li, Junjie Xu, Hong Zhang, Yan Li, Shijie Lv, Wensen Liu, Huiyan Wang
Dihydroartemisinin induces apoptosis and downregulates glucose metabolism in JF-305 pancreatic cancer cells. RSC advances 8 (37) (2018)